logo
MyChart access returning to Kettering Health patients: Update

MyChart access returning to Kettering Health patients: Update

Yahoo10-06-2025
DAYTON, Ohio (WDTN) — More systems are returning to normal operation as Kettering Health continues to recover from the May 20 cyberattack.
According to Kettering Health officials, MyChart is once again available to patients with nearly all of its functionality.
Kettering Health patients speak out on aftermath of cyberattack
Patients can use MyChart to schedule and view upcoming appointments, view prescription lists, message providers and view test results.
Kettering Health says patients may receive extra notifications from MyChart as they continue to restore patient data to EPIC, their electronic medical record system.
'This process— called 'backfill'— updates patient records in real time. When that happens, MyChart automatically sends text and email notifications to let you know,' said Kettering Health.
Officials remind patients to remain vigilant when reviewing any digital communications, as there are still reports of several scams surfacing after the cyberattack.
For more information and frequently asked questions, visit Kettering Health's website.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Philips partners with Epic to integrate cardiac monitoring services
Philips partners with Epic to integrate cardiac monitoring services

Yahoo

time2 days ago

  • Yahoo

Philips partners with Epic to integrate cardiac monitoring services

Royal Philips has entered a partnership with Epic for integrating its cardiac monitoring and diagnostics services suite with the latter's diagnostics suite Aura. This move aims to provide the comprehensive cardiac care portfolio available through Aura. The integration is expected to enhance interoperability between Philips' technologies and Epic, facilitating improved diagnostic processes and patient results. With the integration, health system IT teams will be able to witness a reduction in the time required to engage with Philips. This would enable provider organisations to order and review the ECG results of patients directly within Epic, eliminating the requirement for manual work and data entry. The streamlined process is designed to improve workflows for providers and support care decisions. Philips ambulatory monitoring and diagnostics business leader Stefano Folli said: 'Together, Philips and Epic can help enable workflow efficiencies that lighten cardiac care teams' load, so they can spend more time focusing on what matters most – providing direct patient care.' The partnership between Philips and Epic also aims to simplify administrative tasks by automating staff notifications, patient activation, and charting. This could provide cardiology teams with more time to focus on direct patient care. Epic cardiology and imaging diagnostics vice-president Leah Johnson said: 'When a physician prescribes a cardiac monitor, it allows patients to be evaluated for heart conditions as they go about their daily lives, even before they see a cardiologist. 'Through this collaboration, we're streamlining the clinical experience for both patients and physicians, reducing administrative overhead and ensuring that detailed diagnostic reports are readily available in the patient's comprehensive health record.' Philips' ambulatory portfolio includes remote monitoring along with enterprise ECG management solutions. Earlier this year, Philips and Massachusetts General Brigham collaborated to develop and deploy AI and advanced data infrastructure. "Philips partners with Epic to integrate cardiac monitoring services" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Air Quality Health Advisory issued for NYC, Long Island
Air Quality Health Advisory issued for NYC, Long Island

Yahoo

time3 days ago

  • Yahoo

Air Quality Health Advisory issued for NYC, Long Island

NEW YORK (PIX11) — An Air Quality Health Advisory has been issued for the New York City Metro regions and Long Island from 11 a.m. to 11 p.m. Friday. Individuals with cardiovascular and respiratory diseases, including asthma, should limit strenuous physical activity outdoors. Children and the elderly are also urged to take precautions. More Local News The Air Quality Index value is expected to climb above 100 due to ozone. A heat advisory has also been issued as high heat and humidity are set to return. The advisory runs from 11 a.m. to 8 p.m. as daytime temperatures are expected to reach the mid-90s. During periods of extreme heat, cooling centers will open throughout New York, providing spaces with air conditioning. For more cooling centers, click here or contact 311. Ben Mitchell is a digital content producer from Vermont who has covered both local and international news since 2021. He joined PIX11 in 2024. See more of his work here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword

What to Expect From Cooper Companies' Q3 2025 Earnings Report
What to Expect From Cooper Companies' Q3 2025 Earnings Report

Yahoo

time3 days ago

  • Yahoo

What to Expect From Cooper Companies' Q3 2025 Earnings Report

San Ramon, California-based The Cooper Companies, Inc. (COO) develops, manufactures, and markets contact lens wearers. Valued at a market cap of $14.8 billion, the company also focuses on family and women's health care, providing fertility products and services, medical devices, contraception, and cryostorage to health care professionals and patients. It is scheduled to announce its fiscal Q3 earnings for 2025 after the market closes on Wednesday, Aug. 27. Before this event, analysts project this vision and women's healthcare company to report a profit of $1.06 per share, up 10.4% from $0.96 per share in the year-ago quarter. The company has met or surpassed Wall Street's bottom-line estimates in each of the last four quarters. Its earnings of $0.96 per share in the previous quarter outpaced the consensus estimates by 3.2%. More News from Barchart UnitedHealth Stock Spirals Lower Again. Don't Buy the Dip. This Self-Driving Car Stock Is Surging on a Major Nvidia Boost Auto Revenue Keeps Plunging at Tesla. Should You Buy the TSLA Stock Dip or Run Far Away? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! For the full year, analysts expect COO to report EPS of $4.06, up 10% from $3.69 per share in fiscal 2024. Furthermore, its EPS is expected to grow 9.9% year-over-year to $4.46 in fiscal 2026. Shares of COO have declined 19.8% over the past 52 weeks, lagging behind both the S&P 500 Index's ($SPX) 17.3% uptick and the Health Care Select Sector SPDR Fund's (XLV) 9.4% drop over the same time frame. Despite delivering better-than-expected Q2 results on May 29, shares of COO plunged 14.6% in the following trading session. Due to growth in both of its reportable segments, the company's overall revenue improved 6.3% year-over-year to $1 billion, exceeding consensus expectations. Moreover, its adjusted EPS of $0.96 advanced 12.9% from the year-ago quarter, topping analyst estimates by 3.2%. Wall Street analysts are moderately optimistic about COO's stock, with an overall "Moderate Buy" rating. Among 15 analysts covering the stock, 10 recommend "Strong Buy," one indicates a "Moderate Buy," and four advise 'Hold.' The mean price target for COO is $92.93, implying a 25.9% premium from the current levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store